NPTH Stock Chart & Stats
C$0.55
C$0.06(10.53%)
At close: 4:00 PM EDT
C$0.55
C$0.06(10.53%)
Day’s Range― - ―
52-Week RangeC$0.29 - C$0.68
Previous CloseN/A
Volume198.38K
Average Volume (3M)46.72K
Market Cap
C$28.34M
Enterprise ValueC$49.31
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)21.3
Beta1.14
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding55,030,310
10 Day Avg. Volume24,476
30 Day Avg. Volume46,720
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.68Price Target Upside23.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)0.07
Revenue Forecast (FY)C$93.50M
Neupath Health Inc. News
NPTH FAQ
What was Neupath Health Inc.’s price range in the past 12 months?
Neupath Health Inc. lowest stock price was C$0.28 and its highest was C$0.68 in the past 12 months.
What is Neupath Health Inc.’s market cap?
Neupath Health Inc.’s market cap is C$28.34M.
When is Neupath Health Inc.’s upcoming earnings report date?
Neupath Health Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 55 days.
How were Neupath Health Inc.’s earnings last quarter?
Neupath Health Inc. released its earnings results on Aug 13, 2026. The company reported C$0.026 earnings per share for the quarter, beating the consensus estimate of C$0.02 by C$0.006.
Is Neupath Health Inc. overvalued?
According to Wall Street analysts Neupath Health Inc.’s price is currently Undervalued.
Does Neupath Health Inc. pay dividends?
Neupath Health Inc. does not currently pay dividends.
What is Neupath Health Inc.’s EPS estimate?
Neupath Health Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Neupath Health Inc. have?
Neupath Health Inc. has 55,030,310 shares outstanding.
What happened to Neupath Health Inc.’s price movement after its last earnings report?
Neupath Health Inc. reported an EPS of C$0.026 in its last earnings report, beating expectations of C$0.02. Following the earnings report the stock price went down -6.25%.
Which hedge fund is a major shareholder of Neupath Health Inc.?
Currently, no hedge funds are holding shares in TSE:NPTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Neupath Health Inc.
NeuPath Health Inc is a service provider in the highly fragmented chronic pain management market and operates around 12 chronic pain management clinics across Ontario under two brands CPM - Centers for Pain Management and InMedic Creative Medicine. Traditional medical treatments are supplemented with access to medicinal cannabis, NeuPath's Chronic Pain Self Management Program, and mindfulness meditation. In addition, the multimodal approach provides patients with the education and tools needed to help self-manage their chronic condition. NeuPath's provides patients with the care and tools they need to live a complete and fulfilled life; to reclaim the daily life activities that have been taken by injury or illness.
NPTH Stock 12 Month Forecast
Average Price Target
C$0.68
▲(23.64% Upside)
Technical Analysis
Cardiocomm Solutions
―
Reliq Health Technologies
―
HEALWELL AI
―
Kovo HealthTech Corporation
―
CareSpan Health
―